tailieunhanh - No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone

Chondrosarcoma is a malignant cartilage forming bone tumour for which no effective systemic treatment is available. Previous studies illustrate the need for a better understanding of the role of the IGF pathway in chondrosarcoma to determine if it can be a target for therapy, which was therefore explored in this study. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN